Saturday, April 16, 2022 11:45:17 AM
Just us two here for now.
I have a question(s) for you.
HNRA is acquiring Cunningham Energy closing June 30th, 2022.
Why does the Seeking Alpha author state that he does not have faith in HNRA's ability to line up acquisitions?
HNRC stated that the dividend from HNRA will be .17 if trading above $10.00 and .20 if trading above $12.00 and .33 if trading above $20.00
What if it is trading below $10.00? No dividend? If that is the case, that sure would give incentive for the shorts to whack HNRA as that would then have a negative impact on HNRC pps which we already know shorts have a position in.
Recent HNRA News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 01:45:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 01:30:19 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 08:11:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:00:24 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/09/2024 02:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 02:05:08 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/24/2023 09:55:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2023 09:30:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:30:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:30:25 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:27 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 11/07/2023 10:26:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 12:40:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:30:10 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/30/2023 12:00:12 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/18/2023 01:00:03 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/17/2023 12:45:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/17/2023 12:40:43 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 10/13/2023 06:41:54 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 10/10/2023 03:14:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/13/2023 08:37:20 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM